Dimendone 23mg (Donepezil Hydrochloride Hydrate)

Adult dose

This medication should be taken once daily right before bedtime and can be administered regardless of food intake. The initial recommended dose of Donepezil Hydrochloride is 5mg taken once daily. After administering 5mg for 4-6 weeks, the clinical response should be assessed, and it may be increased to 10mg. When increasing to 10mg per day, caution should be taken for gastrointestinal adverse reactions. Patients may take 10mg once daily for at least 3 months.

This medication should not be taken by women who are allergic to certain ingredients, are pregnant or breastfeeding, and patients with lactase deficiency. Patients with heart disease, a history of gastric ulcers, asthma, or chronic obstructive pulmonary disease should use this medication with caution and closely monitor their condition under medical supervision. Serious side effects such as arrhythmias, gastrointestinal bleeding, liver dysfunction, neurological symptoms, movement disorders, muscle problems, dyspnea, pancreatitis, and renal failure may occur during the course of this medication, and any abnormal symptoms should immediately be reported to a healthcare provider. Common side effects may include nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headaches, and fatigue. If these symptoms persist or worsen, consult a physician. This medication is used for the treatment of Alzheimer's type dementia, and it is important to regularly evaluate therapeutic effects and side effects to determine whether to continue or discontinue use. Patients with heart disease or electrolyte imbalances may require heart monitoring, as this medication can affect heart rhythms, so caution is advised. This medication may promote gastric acid secretion and gastrointestinal motility, so patients with peptic ulcers should monitor for symptom exacerbation. Be cautious when driving or operating machinery during the course of treatment, as fatigue or dizziness may occur. Pregnant or breastfeeding women should ideally avoid using this medication and should consult healthcare providers if breastfeeding needs to be discontinued for necessary cases. Safety in pediatric patients has not been established, so this medication should not be administered to children. There may be interactions with other medications, so inform your healthcare provider if you are currently taking other drugs. In case of overdose, dangerous symptoms such as vomiting, decreased heart rate, and respiratory depression may occur, necessitating immediate emergency care. Store this medication out of reach of children and do not transfer it to another container for safety.

Serious side effects

Syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, heart failure, peptic ulcers, perforated duodenal perforation, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, seizures, epilepsy, convulsions, cerebral hemorrhage, cerebrovascular disorders, extrapyramidal disorders (motor dysfunction, ataxia, movement disorder, dystonia, tremors, involuntary movements, gait problems, abnormal posture, speech disorders), neuroleptic malignant syndrome (akinesia, mutism, extreme muscle stiffness

Mild side effects

• Nausea
• vomiting
• diarrhea
• loss of appetite
• headache
• fatigue
• malaise
• dizziness
• drowsiness
• insomnia

This medication should be stored in a tightly sealed container to prevent air ingress and kept at room temperature between 1 and 30 degrees Celsius. This will help maintain its effectiveness and prevent deterioration.

Appearance

Red, round, biconvex film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle